D-penicillamine therapy and interstitial lung disease in scleroderma. a long-term followup study-Reference-Cited by-同舟云学术

D-penicillamine therapy and interstitial lung disease in scleroderma. a long-term followup study

Published:1987-06 Issue:6 Volume:30 Page:643-650
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Clerck Luc S. De,Dequeker Jan,Francx Luc,Demedts Maurits

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference50 articles.

1. : Progressive systemic sclerosis (scleroderma), Arthritis and Allied Conditions. Ninth edition. Edited by Philadelphia, Lea &Febiger, 1979, pp 762–809

2. Pathologic observations in systemic sclerosis (scleroderma)

3. : Scleroderma (systemic sclerosis), Textbook of Rheumatology. Edited by ED , , . Philadelphia, WB Saunders, 1981, pp 1211–1230

4. OBSERVATIONS ON THE USE OF PREDNISONE IN PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA)

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review;RMD Open;2023-11

2. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease;European Respiratory Review;2018-05-15

3. Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards;Rheumatology;2014-08-13

4. Treatment of interstitial lung diseases associated with connective tissue diseases;Expert Review of Clinical Pharmacology;2012-03

5. Corneal Disease Associated with Nonrheumatoid Collagen-Vascular Disease;Cornea;2011